Mutations in the tumor suppressor APC are more prevalent in BRAF wild type colorectal cancers independently of the presence or absence of concomitant PIK3CA mutations in both cohorts (Fisher’s exact test p < 0.0001 for the comparisons in both cohorts, Figure 2A,B). This evidence concerns the gene PIK3CA and colorectal cancer.